HDFC Pharma and Healthcare Fund Regular Plan IDCW Reinvestment vs Tata India Pharma and Healthcare Fund Regular Plan Growth
NAV, returns and costs — not a recommendation.
 HDFC Pharma and Healthcare Fund Regular Plan IDCW Reinvestment |  Tata India Pharma and Healthcare Fund Regular Plan Growth | |
|---|---|---|
| NAV | ₹21.181 | ₹32.3705 |
| NAV date | 2026-09-30 | 2026-09-30 |
| 1 year | +26.37% | +7.91% |
| 3 year (p.a.) | +28.69% | +17.09% |
| 5 year (p.a.) | +28.69% | +12.49% |
| Expense ratio | 1.97% | 1.84% |
| Fund size | ₹2362.44 Cr | ₹1386.99 Cr |
| Risk | — | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.